icONE: The World's First AI-Powered Embryo Prediction System Wins 2025 ASPIRE Best Oral Presentation Award

AN-AN IVF Reproductive Medicine Group, the Center for Genomic Medicine at National Cheng Kung University, and MedGene Biotechnology jointly developed the world's first intelligent high-quality embryo prediction system icONE, which won the highest honor "Best Oral Presentation Award" at the 2025 ASPIRE (Asia Pacific Society for Reproductive Medicine) Congress.

Innovative AI Technology: Precise Assessment, Enhanced Implantation Success

The icONE system precisely integrates clinical information, embryo differentiation data, and genetic sequencing data, utilizing artificial intelligence algorithms for analysis to accurately assess embryo vitality and quality, assisting clinical physicians in selecting high-quality embryos for implantation and improving implantation success rates. It effectively assists couples trying to conceive, shortening the waiting time for pregnancy and successfully welcoming healthy babies.

Improving Single Embryo Transfer Success Rate, Protecting Maternal and Child Health

Through the icONE system's selection of the most promising embryos for implantation, it improves single embryo transfer success rates and reduces multiple pregnancy rates. This not only alleviates the physiological burden on mothers but also effectively reduces maternal and child health risks such as premature birth, low birth weight infants, and other related complications, providing a safer and healthier pregnancy environment for newborns and mothers.

Internationally Recognized Taiwan Excellence: FDA-Certified Breakthrough Technology

icONE has not only received recognition from the National Innovation Awards but has also passed US FDA certification, proving that Taiwan's reproductive medical technology has reached international top-tier standards. This achievement has made Taiwan stand out in the global reproductive medicine field, bringing new treatment options for global infertility treatment.

Cross-Disciplinary Collaboration Realizing New Vision for Technology-Assisted Reproduction

The cross-disciplinary collaboration between AN-AN IVF Medical Reproductive Group, National Cheng Kung University Genomics Medicine Center, and MagGen Biotechnology combines clinical medical expertise, genetic technology, and artificial intelligence analysis capabilities to provide the latest reproductive technology for families eager to conceive new life. We will continue to deepen our research and development, expand the application scope of icONE technology, and help more families expecting new life realize their wishes.

You Are My Only One—  icONE — The Smart Choice for Happy Conception